Jasmine D Gonzalvo
Overview
Explore the profile of Jasmine D Gonzalvo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez M, Kimiecik C, Nunez J, Suarez J, Garcia G, Struewing M, et al.
Am J Pharm Educ
. 2024 Jul;
88(8):100751.
PMID: 38960069
Objective: This study aimed to present findings from an evaluation of the Spanish Language Track (SLT) for student pharmacists, which assessed student outcomes and feedback. Methods: A mixed-methods program evaluation...
2.
Herrarte C, Martinez M, Gonzalvo J, Davis B, Thoma L, Campbell N
J Am Pharm Assoc (2003)
. 2024 May;
64(4S):102113.
PMID: 38705467
Background: Tricyclic antidepressants (TCAs) are a treatment option for diabetic peripheral neuropathy (DPN). Existing evidence demonstrates the prolonged use of TCA therapy increases the risk of cognitive decline and dementia,...
3.
Crowe S, Kimiecik C, Adeoye-Olatunde O, Conklin M, Smith J, Pastakia S, et al.
J Clin Transl Sci
. 2024 May;
8(1):e66.
PMID: 38690220
A decline in routine vaccinations, attributed to vaccine hesitancy, undermines preventative healthcare, impacting health and exacerbating vaccine disparities. University-public health partnerships can improve vaccination services. This study describes and evaluates...
4.
Hudmon K, Czarnik J, Lahey A, Crowe S, Conklin M, Corelli R, et al.
Pharmacy (Basel)
. 2023 Apr;
11(2).
PMID: 37104078
To address gaps in care for individuals from under-resourced communities disproportionately affected by tobacco use, this pharmacist-led demonstration project evaluated the feasibility of implementing tobacco use screening and brief cessation...
5.
Gonzalvo J, Meredith A, Pastakia S, Peters M, Eberle M, Schmelz A, et al.
PLoS One
. 2023 Mar;
18(3):e0282940.
PMID: 36920963
Background: Reductions in hemoglobin A1c (HbA1C) have been associated with improved cardiovascular outcomes and savings in medical expenditures. One public health approach has involved pharmacists within primary care settings. The...
6.
Schillinger D, Bullock A, Powell C, Fukagawa N, Greenlee M, Towne J, et al.
Diabetes Care
. 2023 Jan;
46(2):e24-e38.
PMID: 36701595
The etiology of type 2 diabetes is rooted in a myriad of factors and exposures at individual, community, and societal levels, many of which also affect the control of type...
7.
Patel J, Gonzalvo J, Eckert G, Schmelz A, Bhatwadekar A
J Pharm Pract
. 2022 Nov;
37(2):383-390.
PMID: 36325719
There are three major microvascular complications of diabetes, retinopathy, nephropathy, and neuropathy, among which diabetic retinopathy (DR) is the most common. Several studies suggest that the Hispanic/LatinX population exhibit the...
8.
Rodriguez N, Ruiz Y, Meredith A, Kimiecik C, Adeoye-Olatunde O, Kimera L, et al.
BMC Health Serv Res
. 2022 Jan;
22(1):117.
PMID: 35086545
Background: An interest in, and the need for, Community Health Workers (CHWs) in the United States is growing exponentially. CHWs possess a unique ability to relate to and build trust...
9.
Leidy S, Hull L, Macik M, Gonzalvo J, Weddle K
J Oncol Pharm Pract
. 2021 Nov;
29(1):66-73.
PMID: 34726099
Introduction: Eskenazi Health in Indianapolis, Indiana, USA. services diverse communities in Central Indiana, including the Hispanic/Latinx community. It has been postulated that this population experiences toxicities at a higher rate...
10.
Meredith A, Buatois E, Krenz J, Walroth T, Shenk M, Triboletti J, et al.
J Eval Clin Pract
. 2020 Jun;
27(2):365-370.
PMID: 32548871
Rationale, Aims And Objectives: Clinical inertia, defined as a delay in treatment intensification, is prevalent in people with diabetes. Treatment intensification rates are as low as 37.1% in people with...